Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedAug 17, 2022Racepinephrine Inhalation SolutionCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1325-2022Class IITerminatedAug 17, 2022Asthmanefrin Racephinephrine Inhalation Solution BronchodilatorCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1324-2022Class IITerminatedAug 17, 2022Dakin's SolutionCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1323-2022Class IITerminatedAug 17, 2022A&D Original OintmentCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1322-2022Class IITerminatedAug 17, 2022Pataday, Once Daily ReliefCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1321-2022Class IITerminatedAug 17, 2022GenTeal TearsCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1320-2022Class IITerminatedAug 17, 2022MiralaxCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1319-2022Class IITerminatedAug 17, 2022Debrox, Carbamide PeroxideCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1318-2022Class IITerminatedAug 17, 2022Systane ZaditorCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1317-2022Class IITerminatedAug 17, 2022Systane BalanceCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1316-2022Class IITerminatedAug 17, 2022Eye-streamCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1315-2022Class IITerminatedAug 17, 2022Systane, Lubricant Eye DropsCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1314-2022Class IITerminatedAug 17, 2022Naphcon A eye dropsCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1313-2022Class IITerminatedAug 17, 2022Bisacodyl SuppositoriesCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1312-2022Class IITerminatedAug 17, 2022Triple Antibiotic OintmentCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1311-2022Class IITerminatedAug 17, 2022Lorazepam InjectionFailed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.Hikma Pharmaceuticals USA Inc. · D-1310-2022Class IITerminatedAug 17, 2022Lorazepam InjectionFailed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.Hikma Pharmaceuticals USA Inc. · D-1309-2022Class IITerminatedAug 17, 2022Ativan InjectionFailed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.Hikma Pharmaceuticals USA Inc. · D-1308-2022Class IITerminatedAug 17, 2022Lorazepam InjectionFailed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.Hikma Pharmaceuticals USA Inc. · D-1307-2022Class IITerminatedAug 17, 2022Telmisartan and Hydrochlorothiazide Tablets USPDefective Container: Recall of these batches has been initiated due to complaints of difficult to open blister and tablet breaks while opening the blister .Glenmark Pharmaceuticals Inc., USA · D-1306-2022Class IITerminatedAug 17, 2022Telmisartan and Hydrochlorothiazide Tablets USPDefective Container: Recall of these batches has been initiated due to complaints of difficult to open blister and tablet breaks while opening the blister .Glenmark Pharmaceuticals Inc., USA · D-1305-2022Class ITerminatedAug 10, 2022SUSTANGOMarketed Without an Approved NDA/ANDA: Analytical testing showed the presence of tadalafil.Ultra Supplement LLC · D-1350-2022Class ITerminatedAug 10, 2022SANGTER Energy Supplement CapsulesMarketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil.Distributor RFR, LLC. · D-1333-2022Class IIIOngoingAug 10, 2022Tacrolimus OintmentDefective Container: Tube split from side seamGlenmark Pharmaceuticals Inc., USA · D-1304-2022Class IITerminatedAug 10, 2022Matzim LAFailed Dissolution Specifications: below specification limits for dissolution.Teva Pharmaceuticals USA Inc · D-1303-2022Class IITerminatedAug 10, 2022Matzim LAFailed Dissolution Specifications: below specification limits for dissolution.Teva Pharmaceuticals USA Inc · D-1302-2022Class IITerminatedAug 10, 2022Naftifine Hydrochloride GelFailed Impurities/ degradation specifications: Out-of-Specification test results obtained for Unspecified Impurity Relative Retention TimeTolmar, Inc. · D-1300-2022Class ITerminatedAug 3, 2022Propofol Injectable EmulsionPresence of particulate matter: particulate identified as a beetle.Pfizer Inc. · D-1301-2022Class IIITerminatedAug 3, 2022Juice BeautyFailed Dissolution SpecificationsEco Lips, Inc · D-1299-2022Class IIITerminatedAug 3, 2022Juice BeautyFailed Dissolution SpecificationsEco Lips, Inc · D-1298-2022Class IITerminatedAug 3, 2022Irbesartan TabletsFailed Dissolution SpecificationsJubilant Cadista Pharmaceuticals, Inc. · D-1294-2022Class IITerminatedAug 3, 2022Irbesartan TabletsFailed dissolution specifications.Jubilant Cadista Pharmaceuticals, Inc. · D-1293-2022Class ITerminatedAug 3, 2022Insulin GlargineLabeling: Missing label: Label missing from some prefilled pens.Mylan Pharmaceuticals Inc · D-1292-2022Class IITerminatedAug 3, 2022Divalproex Sodium Delayed-Release TabletsFailed Dissolution Specifications: Failure occurred during routine stability testing of dissolution test.Sun Pharmaceutical Industries Inc · D-1291-2022Class IIICompletedAug 3, 2022Crest 3D White Fluoride Anticavity ToothpasteLabeling: Missing label: the product tube was missing a label and contained a different formulation.The Procter & Gamble Company · D-1290-2022Class IITerminatedAug 3, 2022Testosterone Gel 1%Superpotent Drug: Out of specification assay result was obtained during stability testing.Teva Pharmaceuticals USA Inc · D-1289-2022Class IITerminatedAug 3, 2022Lansoprazole Delayed-Release Orally Disintegrating TabletsFAILED DISSOLUTION SPECIFICATIONSDr. Reddy's Laboratories, Inc. · D-1288-2022Class IITerminatedAug 3, 2022Lansoprazole Delayed-Release Orally Disintegrating TabletsFAILED DISSOLUTION SPECIFICATIONSDr. Reddy's Laboratories, Inc. · D-1287-2022Class ITerminatedAug 3, 2022Nifedipine WSP 0.2% OintmentSubpotent and Superpotent DrugValor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy · D-1286-2022Class IITerminatedJul 27, 2022Launch Sequence Aphrodisia CapsulesMarketed Without An Approved NDA/ANDA: Unapproved Drug based on label claims.Loud Muscle Science · D-1341-2022

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.